Although we updated our earlier dispatch to report that the drugmaker is eliminating 1,000 sales positions, we thought we would take this opportunity to bring you the latest. In addition to the sales jobs - about half of which are currently vacated - Glaxo is closing its plant in Cidra, Puerto Rico, citing excess capacity, according to a Glaxo spokeswoman.

“We expect the workforce will reduce from approximately 900 to approximately 250 by the end of 2007,” she tells Pharmalot. “The Cidra factory was established in 1969 and most recently manufactured Coreg, Avandia, Avandamet, and Paxil CR. Manufacture of those products will or have been transferred into other sites.”

As more details become known, we will fill you in.